Form 4 Filing for CYTOKINETICS INC - Officer/Director Transaction

Nancy Wysenski, a director at CYTOKINETICS INC (CYTK), acquired 95 shares of common stock on April 15, 2026, valued at 65.37 per share. These shares were granted under the Director Equity in Lieu of Cash Retainer Program and are fully vested. Following this transaction, Wysenski owns 31,066 shares. The transaction code indicates an acquisition, and the ownership is direct.